Cargando…
Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases
Fibrosis is likely to occur in many tissues and organs to induce cicatrisation and dysfunction. The therapeutic regimens for delaying and even reversing fibrosis are quite limited at present. In nearly a decade, mesenchymal stem cells (MSCs) have been widely acknowledged as useful in treating fibrot...
Autores principales: | Huang, Yuling, Yang, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334330/ https://www.ncbi.nlm.nih.gov/pubmed/34348793 http://dx.doi.org/10.1186/s13287-021-02524-1 |
Ejemplares similares
-
Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases
por: Huang, Yuling, et al.
Publicado: (2021) -
Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment
por: Huang, Yuling, et al.
Publicado: (2022) -
Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases
por: Gubert, Fernanda, et al.
Publicado: (2021) -
Functional proteins of mesenchymal stem cell-derived extracellular vesicles
por: Qiu, Guanguan, et al.
Publicado: (2019) -
Mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles: Potential roles in rheumatic diseases
por: Yang, Jing-Han, et al.
Publicado: (2020)